Literature DB >> 26961662

Total testosterone levels are correlated to metabolic syndrome components.

Rodrigo Blaya1, Leonardo Dalla Giacomassa Rocha Thomaz2, Fernanda Guilhermano2, Artur de Oliveira Paludo2, Luiza Rhoden3, Graziele Halmenschlager4, Ernani Luis Rhoden5.   

Abstract

INTRODUCTION: Metabolic syndrome (MetS) is a constellation of interrelated risk factors of metabolic origin. Some studies suggest a possible link between low total testosterone (TT) levels and the presence of MetS. AIM: To analyze the strength and independence of associations between TT and MetS components in non-diabetic men.
METHODS: In this cross-sectional study, 143 non-diabetic men older than 40 were analyzed. MAIN OUTCOMES MEASURE: Blood samples were collected to evaluate metabolic profile and TT levels. MetS was defined as the presence of three or more of the following characteristics: fasting blood glucose levels ≥ 100 mg/dL, triglyceride ≥ 150 mg/dL, HDL-c < 40 mg/dL, hypertension or blood pressure ≥ 130/85 mmHg, and waist girth > 102 cm.
RESULTS: Mean age of the study population was 61.5 ± 8.61 years old. MetS was present in 47.9% of the individuals. Thirty-four men had low TT and MetS was observed in 23 (70%) against 50 (46%) in those with normal TT (≥ 300 ng/dL) (OR 4.94, p < 0.01), adjusted to confounder's factors. In multiple linear regression analysis, only waist circumference (Beta: -0.395; p = 0.03) and HDL-c (Beta: 0.19; p = 0.04) remained significantly correlated with TT levels.
CONCLUSIONS: Low TT levels were associated with MetS diagnosis. Abdominal obesity was the MetS component independently correlated to low TT levels.

Entities:  

Keywords:  Testosterone; abdominal obesity; hypogonadism; insulin resistance; metabolic syndrome X; waist circumference

Mesh:

Substances:

Year:  2016        PMID: 26961662     DOI: 10.3109/13685538.2016.1154523

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  11 in total

Review 1.  The emerging role of obesity, diet and lipid metabolism in prostate cancer.

Authors:  Matteo Ferro; Daniela Terracciano; Carlo Buonerba; Giuseppe Lucarelli; Danilo Bottero; Sisto Perdonà; Riccardo Autorino; Alessandro Serino; Francesco Cantiello; Rocco Damiano; Iulia Andras; Sabino De Placido; Giuseppe Di Lorenzo; Michele Battaglia; Barbara A Jereczek-Fossa; Vincenzo Mirone; Ottavio De Cobelli
Journal:  Future Oncol       Date:  2016-09-14       Impact factor: 3.404

2.  Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells.

Authors:  C Antinozzi; F Marampon; C Corinaldesi; E Vicini; P Sgrò; G B Vannelli; A Lenzi; C Crescioli; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-05-15       Impact factor: 4.256

3.  Testosterone and All-Cause Mortality in Older Men: The Role of Metabolic Syndrome.

Authors:  Nasser Laouali; Sylvie Brailly-Tabard; Catherine Helmer; Marie-Laure Ancelin; Christophe Tzourio; Archana Singh-Manoux; Aline Dugravot; Alexis Elbaz; Anne Guiochon-Mantel; Marianne Canonico
Journal:  J Endocr Soc       Date:  2018-02-26

4.  Association of total testosterone, free testosterone, bioavailable testosterone, sex hormone-binding globulin, and hypertension.

Authors:  Qingtao Yang; Zhenjie Li; Wencai Li; Liang Lu; Haoqiang Wu; Yiyi Zhuang; Kusheng Wu; Xuxia Sui
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review.

Authors:  Suguru Kadomoto; Kazuyoshi Shigehara; Hiroaki Iwamoto; Hiroshi Yaegashi; Kouji Izumi; Yoshifumi Kadono; Atsushi Mizokami
Journal:  World J Mens Health       Date:  2019-05-02       Impact factor: 5.400

Review 6.  The Role of Testosterone in the Elderly: What Do We Know?

Authors:  Biagio Barone; Luigi Napolitano; Marco Abate; Luigi Cirillo; Pasquale Reccia; Francesco Passaro; Carmine Turco; Simone Morra; Francesco Mastrangelo; Antonio Scarpato; Ugo Amicuzi; Vincenzo Morgera; Lorenzo Romano; Francesco Paolo Calace; Savio Domenico Pandolfo; Luigi De Luca; Achille Aveta; Enrico Sicignano; Massimiliano Trivellato; Gianluca Spena; Carlo D'Alterio; Giovanni Maria Fusco; Raffaele Vitale; Davide Arcaniolo; Felice Crocetto
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

7.  Testosterone: Relationships with Metabolic Disorders in Men-An Observational Study from SPECT-China.

Authors:  Jing Cheng; Bing Han; Qin Li; Fangzhen Xia; Hualing Zhai; Ningjian Wang; Michael Jensen; Yingli Lu
Journal:  Int J Endocrinol       Date:  2017-12-03       Impact factor: 3.257

Review 8.  Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome.

Authors:  Abdulmaged M Traish; Vanessa Johansen
Journal:  World J Mens Health       Date:  2018-07-03       Impact factor: 5.400

9.  Cross-Sectional Inverse Associations of Obesity and Fat Accumulation Indicators with Testosterone in Non-Diabetic Aging Men.

Authors:  Iwona Rotter; Aleksandra Rył; Katarzyna Grzesiak; Aleksandra Szylińska; Wioletta Pawlukowska; Anna Lubkowska; Olimpia Sipak-Szmigiel; Krzysztof Pabisiak; Maria Laszczyńska
Journal:  Int J Environ Res Public Health       Date:  2018-06-08       Impact factor: 3.390

10.  Association of free androgen index and sex hormone-binding globulin and left ventricular hypertrophy in postmenopausal hypertensive women.

Authors:  Chen Jianshu; Wang Qiongying; Pei Ying; Li Ningyin; Han Junchen; Yu Jing
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-06-09       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.